Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Duster340 on Feb 27, 2021 11:20pm

Robert Mcwhirter

very optimistic, $20 stock upon successful p3 results.  time 5:02 mark
Comment by 123ABC on Feb 28, 2021 5:13am
Lol, $20 after phase 3, stock should be worth more before then.
Comment by 3burtc on Feb 28, 2021 7:28am
He also let the cat out of the bag suggesting that big pharma will be involved in phase 3. He looked very nervous. Maybe because he slipped up?
Comment by Chianchin on Feb 28, 2021 11:34am
He bought in cheap on the pp and cannot overstrech the target price. Wait a few months and the target goes up. The share price need to go lower . Now all is fair and ATE got a god deal on the pp. This is how it works when not in the big leages yet. My target $50 
Comment by 3burtc on Feb 28, 2021 12:00pm
It's going lower because the pre market gives the same signal day in day out, to lower the price.
Comment by WalkOverTheStrt on Feb 28, 2021 1:30pm
didn't sound slike he said it was a defiite but more a could happen when i listened to it. 
Comment by bringon10bagger on Feb 28, 2021 1:58pm
Bob is never clear in his messaging, could have plugged latest deal with Nuance, 20M in hand, additional 80m  due in milestones, recent financing top up the bank account to 70m+ and will  finance phase 3, other regional deals imminent, and despite cash to complete phase 3 big pharma could join the party anytime, before, during or after phase 3 trials......imo
Comment by MrMugsy on Feb 28, 2021 3:05pm
Bob is a funny little man - he knows what he know and that's it. I always knew him as a charts guy and once in a while he adds some facts to back up his thoughts.  Other than that - I really don't give him much credit. Once upon a time he butchered his understanding of a little tech company out of Waterloo. Then again - some swear by Bob.
Comment by TriumphSpitSix on Mar 01, 2021 12:54am
McWhirter has no business on television. He's a muttering trainwreck.
Comment by 3burtc on Feb 28, 2021 3:59pm
He did mention Nuance but it looks like it was edited out.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities